8-K: Catheter Precision Amends Promissory Notes, Extends Maturity and Increases Interest Rate

Catheter Precision has amended its short-term promissory notes, extending the maturity date to January 31, 2026, and increasing the interest rate to 12% from August 31, 2024.

Summary

• Catheter Precision amended its outstanding 8% short-term promissory notes.
• The maturity date of these notes has been extended from August 30, 2024, to January 31, 2026.
• The interest rate on the notes will increase from 8% to 12% starting August 31, 2024.
• Interest accrued up to August 30, 2024, will be paid on that date.
• The amendments apply to notes held by David A. Jenkins, FatBoy Capital, L.P., and Jenkins Family Charitable Institute.
• The total principal amount of the amended notes is $1,500,000.

Sentiment

Score: 4

Explanation: The document indicates a worsening financial situation due to increased interest rates and reliance on related-party debt, which is a negative signal for investors.

Positives

• The extension of the maturity date provides Catheter Precision with more time to repay the debt.
• The amendments ensure that the company has continued access to capital from key stakeholders.

Negatives

• The increase in the interest rate to 12% will increase the company's borrowing costs.
• The company is reliant on related parties for financing.

Risks

• The company's reliance on short-term debt and related-party financing could pose a risk if these sources of funding become unavailable.
• The increased interest rate will increase the company's financial burden.
• The company's ability to repay the debt by the new maturity date is not guaranteed.

Future Outlook

The company has extended its debt obligations to January 31, 2026, and will face higher interest payments starting August 31, 2024.

Industry Context

The amendment of promissory notes is a common practice for companies seeking to manage their debt obligations, especially in the development stage. The increased interest rate may reflect the perceived risk associated with the company's financial situation.

Comparison to Industry Standards

• It is common for early-stage medical device companies to rely on debt financing, often from related parties.
• The interest rate of 12% is relatively high, suggesting that the company may have limited access to traditional financing options.
• Comparable companies in the medical device sector often use a mix of equity and debt financing, with interest rates varying based on the company's risk profile and stage of development.

Related Party Transactions

• The promissory notes are held by David A. Jenkins, the Executive Chair and CEO, and entities related to him.
• David A. Jenkins is the managing member of the general partner of FatBoy Capital, L.P., and was the Settlor and Initial Trustee of Jenkins Family Charitable Institute.
• Missiaen Huck, Mr. Jenkins' adult daughter, serves as the company's non-executive chief operating officer.

Stakeholder Impact

• Shareholders may be concerned about the increased debt burden and the company's reliance on related-party financing.
• Creditors, particularly the note holders, will benefit from the higher interest rate.
• Employees may be indirectly affected by the company's financial situation.

Key Dates

Keywords

promissory notes, debt financing, interest rate, maturity date, related party, Catheter Precision, amendment